The American Legion adopted a resolution supporting psychedelic therapies and related research for veterans and service members with PTSD, depression or traumatic brain injury.

At its 107th National Convention in Louisville, Kentucky, The American Legion backed S.4220, the Veterans Health Administration’s Novel Therapeutics Preparedness Act. The bipartisan bill would create a VHA office to coordinate research, clinical guidance and implementation, while preparing VA care models, eligibility rules, safety procedures and clinician training.